CRSP Stock Analysis: Buy, Sell, or Hold?
CRSP - CRISPR Therapeutics AG
$59.16
-1.61 (-2.65%)
▼
5d:
+8.47%
30d:
+14.12%
90d:
+19.03%
BUY
MODERATE Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Aug 03, 2026
25d
Smart Money Distribution
None View Scanner →
Strength: 6.8/10
Get Alerted When CRSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called CRSP this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CRSP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CRSP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CRSP is currently trading at $59.16, which is considered extended relative to its 30-day fair value range of $51.03 to $57.25.
Technical Outlook: Technically, CRSP is in a strong uptrend. Immediate support is located at $53.13, while resistance sits at $63.45.
Market Sentiment: CRSP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $83.52 (+37.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRSP is in a strong uptrend. Immediate support is located at $53.13, while resistance sits at $63.45.
Market Sentiment: CRSP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $83.52 (+37.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$51.03 -
$57.25
Company Quality Score
69/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.4% below Wall St target ($83.52)
Trading Range Analysis
30-Day Trading Range
$51.03 -
$57.25
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$53.13
Resistance Level
$63.45
Current Trend
Strong Uptrend
Technical data as of
Jul 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.87
Wall Street Target
$83.52
(+37.4%)
Revenue Growth (YoY)
68.6%
Share & Embed Analysis
Last updated: July 08, 2026 10:27 AM ET
Data refreshes hourly during market hours. Next update: 11:27 AM
Data refreshes hourly during market hours. Next update: 11:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
James R Kasinger
SELL
3182 shares
2026-03-23
Samarth Kulkarni
SELL
10020 shares
2026-03-23
James R Kasinger
SELL
3450 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 62 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 63 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 49 HOLD |
Advanced CRSP Option Strategies
Professional options setups generated by AI based on today's CRSP price and gamma walls.
